Cargando…
MiR‐148b suppressed non‐small cell lung cancer progression via inhibiting ALCAM through the NF‐κB signaling pathway
BACKGROUND: Non‐small cell lung cancer (NSCLC) is the leading cause of cancer mortality worldwide. MiRNAs are recognized as important molecules in cancer biology. The aim of the study was to identify a novel biomarker miR‐148b and its mechanism in the modulation of NSCLC progression. METHODS: The ex...
Autores principales: | Jiang, Zhe, Zhang, JingWen, Chen, FuHui, Sun, Yajiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997015/ https://www.ncbi.nlm.nih.gov/pubmed/31883226 http://dx.doi.org/10.1111/1759-7714.13285 |
Ejemplares similares
-
NF-κB induces miR-148a to sustain TGF-β/Smad signaling activation in glioblastoma
por: Wang, Hui, et al.
Publicado: (2015) -
miR-130b, an onco-miRNA in bladder cancer, is directly regulated by NF-κB and sustains NF-κB activation by decreasing Cylindromatosis expression
por: Cui, Xiaolu, et al.
Publicado: (2016) -
miR-148b-3p, miR-190b, and miR-429 Regulate Cell Progression and Act as Potential Biomarkers for Breast Cancer
por: Dai, Wenzhu, et al.
Publicado: (2019) -
Analysis of a miR-148a Targetome in B Cell Central Tolerance
por: Ma, Fengge, et al.
Publicado: (2022) -
Targeting miR-148b-5p Inhibits Immunity Microenvironment and Gastric Cancer Progression
por: Zhang, Yuyu, et al.
Publicado: (2021)